1 – 4 of 4
- show: 20
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2019
-
Mark
‘Stealth’ corporate innovation : an emerging threat for therapeutic drug development
(
- Contribution to journal › Debate/Note/Editorial
- 2013
-
Mark
Affinity purification of human factor h on polypeptides derived from streptococcal m protein: enrichment of the y402 variant.
(
- Contribution to journal › Article
- 2012
-
Mark
Sensitive and specific assays for C3 nephritic factors clarify mechanisms underlying complement dysregulation
(
- Contribution to journal › Article
- 2010
-
Mark
Sensitive and specific assays for C3 nephritic factors permit dissection of mechanisms underlying complement dysregulation
(
- Contribution to journal › Published meeting abstract